https://clinicaltrials.gov/ct2/show/NCT03520751
Phase I/IIa Trial Evaluating scAAV1.tMCK.NTF3 for Treatment of Charcot-Marie-Tooth Neuropathy Type 1A (CMT1A)
scAAV1.tMCK.NTF3
Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of Charcot-Marie-Tooth Type 1A (CMT1A)
https://clinicaltrials.gov/ct2/show/NCT03520751?type=Intr&cond=Charcot-Marie-Tooth&lupd_s=11%2F21%2F2018&lupd_d=14
Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A
Condition : Charcot-Marie-Tooth Neuropathy Type 1A
Intervention : Drug: scAAV1.tMCK.NTF3
Sponsor : Nationwide Children’s Hospital
Recruiting
NCT03520751
Thu, 10 May 2018 12:00:00 EDT
Dec 5, 2018 update – start date delayed +3 months from oct 2018 to jan 2019
Feb 20, 2019 update – start date delayed again +6 months from jan 2019 to july 2019
Jun 13, 2019 update – status changed from recruiting to not yet recruiting [is this normal? was it recruiting before? find out]
Oct 16, 2019 update – start date delayed again +6 months from jul 2019 to jan 2020
Nov 19, 2020 update – recruiting
